{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:07:03Z","timestamp":1784088423445,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metachronous upper tract urothelial carcinoma (UTUC) is an uncommon but clinically significant event in patients with non\u2013muscle-invasive bladder cancer (NMIBC), particularly in those with high-risk or recurrent disease. Proposed mechanisms include field cancerization and intraluminal tumor seeding, while ureteric instrumentation has been discussed as a potential contributing factor. Emerging evidence suggests that retrograde ureteric stent placement performed concurrently with transurethral resection of bladder tumor (TURBT) may be associated with an increased risk of subsequent upper tract involvement. We report the first case of bilateral distal ureteric urothelial carcinoma developing in close temporal association with first-time ureteric stent placement in a patient with recurrent NMIBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>A 78-year-old man with recurrent high-grade NMIBC underwent bilateral ureteric stent placement during TURBT for obstructive uropathy, with no prior evidence of UTUC. Within months, imaging demonstrated progressive distal ureteric abnormalities. Subsequent cystoscopy and bilateral ureteroscopy revealed extensive papillary tumors involving both distal ureters with proximal extension, in addition to recurrent bladder lesions. Histopathology confirmed high-grade, non\u2013muscle-invasive urothelial carcinoma. At re-intervention, both indwelling stents were encased within tumor tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the multifactorial nature of metachronous UTUC in patients with recurrent bladder cancer and supports the hypothesis that ureteric instrumentation may contribute to upper tract tumor dissemination in selected high-risk settings. Careful consideration of urinary diversion strategies and close upper tract surveillance remain important when managing patients with active bladder urothelial carcinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-026-02183-5","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:16:14Z","timestamp":1779419774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["When double-J stents become a risk: bilateral distal ureteric urothelial carcinoma following ureteric instrumentation: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Salma","family":"Eldesouki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Elmekresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzeh","family":"Esmaeilpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldon Abo","family":"Alsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham Mahjoor","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2183_CR1","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"issue":"4","key":"2183_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, Chang SS, Holmes R, James AC, et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline: 2024 Amendment. J Urol. 2024;211(4):533\u20138.","journal-title":"J Urol"},{"issue":"7","key":"2183_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijerph21070954","volume":"21","author":"S Alouini","year":"2024","unstructured":"Alouini S. Risk Factors Associated with Urothelial Bladder Cancer. Int J Environ Res Public Health. 2024;21(7):954.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2183_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"issue":"6","key":"2183_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero P, Birtle A, Capoun O, Comp\u00e9rat E, Dominguez-Escrig JL, Liedberg F, et al. European Association of Urology Guidelines on Non\u2013muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)\u2014A Summary of the 2024 Guidelines Update. Eur Urol. 2024;86(6):531\u201349.","journal-title":"Eur Urol"},{"issue":"6","key":"2183_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","volume":"87","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, Birtle A, Pradere B, Capoun O, Comp\u00e9rat E, Dom\u00ednguez-Escrig JL, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update. Eur Urol. 2025;87(6):697\u2013716.","journal-title":"Eur Urol"},{"key":"2183_CR7","doi-asserted-by":"crossref","unstructured":"Pace KJC, Kwong JCC, Randhawa H, Ringa M, Al-Daqqaq Z, Chelliahpillai Y et al. Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer. BJU Int 2025 Nov 19.","DOI":"10.1016\/j.eururo.2025.09.3262"},{"issue":"3","key":"2183_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.eururo.2024.10.024","volume":"87","author":"K Kim","year":"2025","unstructured":"Kim K, Alam SM, Kuo F, Chen Z, Yip W, Katims AB, et al. Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma. Eur Urol. 2025;87(3):342\u201354.","journal-title":"Eur Urol"},{"issue":"4","key":"2183_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/JU.0000000000001548","volume":"205","author":"P Sountoulides","year":"2021","unstructured":"Sountoulides P, Pyrgidis N, Brookman-May S, Mykoniatis I, Karasavvidis T, Hatzichristou D. Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis. J Urol. 2021;205(4):956\u201366.","journal-title":"J Urol"},{"issue":"3","key":"2183_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","volume":"25","author":"F Audenet","year":"2019","unstructured":"Audenet F, Isharwal S, Cha EK, Donoghue MTA, Drill EN, Ostrovnaya I, et al. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. Clin Cancer Res. 2019;25(3):967\u201376.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2183_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.eururo.2020.05.039","volume":"78","author":"MR Hassler","year":"2020","unstructured":"Hassler MR, Bray F, Catto JWF, Grollman AP, Hartmann A, Margulis V, et al. Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. Eur Urol. 2020;78(2):209\u201320.","journal-title":"Eur Urol"},{"issue":"18","key":"2183_CR12","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","volume":"11","author":"TD Jones","year":"2005","unstructured":"Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, et al. Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis. Clin Cancer Res. 2005;11(18):6512\u20139.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2183_CR13","doi-asserted-by":"publisher","first-page":"102241","DOI":"10.1016\/j.clgc.2024.102241","volume":"22","author":"P Scilipoti","year":"2024","unstructured":"Scilipoti P, Moschini M, de Angelis M, Longoni M, Afferi L, Lonati C, et al. Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer. Clin Genitourin Cancer. 2024;22(6):102241.","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"2183_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2020.04.059","volume":"78","author":"JY Teoh","year":"2020","unstructured":"Teoh JY, MacLennan S, Chan VW, Miki J, Lee H, Chiong E, et al. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting. Eur Urol. 2020;78(4):546\u201369.","journal-title":"Eur Urol"},{"issue":"35","key":"2183_CR15","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1038\/sj.onc.1204671","volume":"20","author":"C Hafner","year":"2001","unstructured":"Hafner C, Knuechel R, Zanardo L, Dietmaier W, Blaszyk H, Cheville J, et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene. 2001;20(35):4910\u20135.","journal-title":"Oncogene"},{"issue":"1","key":"2183_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12894-025-01828-1","volume":"25","author":"Z Wu","year":"2025","unstructured":"Wu Z, Qu C, Liang G, Sun R, Lin N, Xie Y, et al. Double-J stenting during TURBT increases risk of metachronous upper tract urothelial carcinoma. BMC Urol. 2025;25(1):146\u201310.","journal-title":"BMC Urol"},{"issue":"6","key":"2183_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.juro.2017.06.020","volume":"198","author":"B Kiss","year":"2017","unstructured":"Kiss B, Furrer MA, Wuethrich PY, Burkhard FC, Thalmann GN, Roth B. Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence. J Urol. 2017;198(6):1263\u20138.","journal-title":"J Urol"},{"key":"2183_CR18","unstructured":"Jain NK, Sokhal AK, Jhanwar A, Lashkary N, Hada S. Does Retrograde Double-J Stenting in Bladder Urothelial Malignancy Predisposes for Tumour Seeding at Upper Urinary Tract: A Study From a Tertiary Care Hospital. 2017 Feb 25."},{"key":"2183_CR19","unstructured":"Babjuk M, Burger M, Comp\u00e9rat E, Gontero P, Mostafid AH, Palou J. EAU guidelines. InEdn. Presented at the EAU Annual Congress Milan 2020 (pp. 13\u2009\u2013\u20095)."},{"key":"2183_CR20","doi-asserted-by":"crossref","unstructured":"Ahmad MU, Siddiqui S, Ashraf FA, Iqbal R, E SAM, AlFayadh A, et al. Retrograde Ureteral Stents Versus Percutaneous Nephrostomy in the Management of Malignant Ureteral Obstruction: A Systematic Review and Meta-Analysis. Urol (Ridgewood N J). 2024;192:158\u201367.","DOI":"10.1016\/j.urology.2024.05.042"},{"issue":"7","key":"2183_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/iju.14235","volume":"27","author":"C Tabib","year":"2020","unstructured":"Tabib C, Nethala D, Kozel Z, Okeke Z. Management and treatment options when facing malignant ureteral obstruction. Int J Urol. 2020;27(7):591\u20138.","journal-title":"Int J Urol"},{"issue":"11","key":"2183_CR22","first-page":"9541","volume":"30","author":"A Shvero","year":"2022","unstructured":"Shvero A, Haifler M, Mahmud H, Dotan Z, Winkler H, Kleinmann N. Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction. Support Care Cancer. 2022;30(11):9541\u20138.","journal-title":"Support Care Cancer"},{"issue":"5","key":"2183_CR23","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1016\/j.jacr.2020.01.039","volume":"17","author":"MJ Scheidt","year":"2020","unstructured":"Scheidt MJ, Hohenwalter EJ, Pinchot JW, Ahmed O, Bjurlin MA, Braun AR, et al. ACR Appropriateness Criteria\u00ae Radiologic Management of Urinary Tract Obstruction. J Am Coll Radiol. 2020;17(5):S281\u201392.","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"2183_CR24","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s00345-023-04547-0","volume":"41","author":"JY Teoh","year":"2023","unstructured":"Teoh JY, D\u2019Andrea D, Gallioli A, Yanagisawa T, MacLennan S, Nicoletti R, Fai NC, Maffei D, Hurle R, Lusuardi L, Malavaud B. En bloc resection of bladder tumour: the rebirth of past through reminiscence. World J Urol. 2023;41(10):2599\u2013606.","journal-title":"World J Urol"},{"key":"2183_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.urology.2024.02.032","volume":"187","author":"M Callegari","year":"2024","unstructured":"Callegari M, Patel A, Drozd A, Rhodes S, Ahrendt H, Jesse E, et al. Novel Antireflux RELIEF Stent to Prevent Vesicoureteral Reflux. Urol (Ridgewood N J). 2024;187:100\u20135.","journal-title":"Urol (Ridgewood N J)"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02183-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:29:23Z","timestamp":1784086163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02183-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patient. A patient perspective was not available for inclusion.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"166"}}